These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 23259710)

  • 1. Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.
    van de Kant KD; van der Sande LJ; Jöbsis Q; van Schayck OC; Dompeling E
    Respir Res; 2012 Dec; 13(1):117. PubMed ID: 23259710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensors for detecting pulmonary diseases from exhaled breath.
    Hashoul D; Haick H
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31243097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
    Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breathomics in lung disease.
    van der Schee MP; Paff T; Brinkman P; van Aalderen WMC; Haarman EG; Sterk PJ
    Chest; 2015 Jan; 147(1):224-231. PubMed ID: 25560860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children - clinical tools or scientific toys?
    van Mastrigt E; de Jongste JC; Pijnenburg MW
    Clin Exp Allergy; 2015 Jul; 45(7):1170-88. PubMed ID: 25394891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exhaled breath analysis for the discrimination of asthma and chronic obstructive pulmonary disease.
    Li L; Chen H; Shi J; Chai S; Yan L; Meng D; Cai Z; Guan J; Xin Y; Zhang X; Sun W; Lu X; He M; Li Q; Yan X
    J Breath Res; 2024 Jul; 18(4):. PubMed ID: 38834048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study.
    Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD
    J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can exhaled volatile organic compounds predict asthma exacerbations in children?
    van Vliet D; Smolinska A; Jöbsis Q; Rosias P; Muris J; Dallinga J; Dompeling E; van Schooten FJ
    J Breath Res; 2017 Mar; 11(1):016016. PubMed ID: 28102830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled volatile organic compounds in adult asthma: a systematic review.
    Azim A; Barber C; Dennison P; Riley J; Howarth P
    Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31273044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients.
    Kos R; Brinkman P; Neerincx AH; Paff T; Gerritsen MG; Lammers A; Kraneveld AD; Heijerman HGM; Janssens HM; Davies JC; Majoor CJ; Weersink EJ; Sterk PJ; Haarman EG; Bos LD; Maitland-van der Zee AH;
    J Cyst Fibros; 2022 Jan; 21(1):e28-e34. PubMed ID: 34016557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis.
    van Mastrigt E; Reyes-Reyes A; Brand K; Bhattacharya N; Urbach HP; Stubbs AP; de Jongste JC; Pijnenburg MW
    J Breath Res; 2016 Apr; 10(2):026003. PubMed ID: 27058305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of measuring exhaled breath biomarkers in sarcoidosis: a systematic review.
    Terrington DL; Hayton C; Peel A; Fowler SJ; Fraser W; Wilson AM
    J Breath Res; 2019 Jun; 13(3):036015. PubMed ID: 30901768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-induced Volatile Organic Compounds Are Detectable in Exhaled Breath during Pulmonary Infection.
    Kamal F; Kumar S; Edwards MR; Veselkov K; Belluomo I; Kebadze T; Romano A; Trujillo-Torralbo MB; Shahridan Faiez T; Walton R; Ritchie AI; Wiseman DJ; Laponogov I; Donaldson G; Wedzicha JA; Johnston SL; Singanayagam A; Hanna GB
    Am J Respir Crit Care Med; 2021 Nov; 204(9):1075-1085. PubMed ID: 34319857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.